Cryogenic OGS
Close ·
Key Fundamentals
SMEIndustrial ManufacturingCapital GoodsPrice-based figures at the close · TTM
- ROCE
- 29.60%
- Debt to Equity
- 0.00
- EPS (TTM)
- —
- Book Value
- ₹38.27
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 8.88
- ROE
- 20.60%
- Dividend Yield
- 0.00%
- EBITDA
- ₹12.90 Cr
- 52W High
- ₹453.00
- 52W Low
- ₹151.00
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 84/100
Category scores
- Quality
- 70
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 37
- Weak
- Cheap vs sector & own history 24% weight
- Growth
- 73
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 88
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 98
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 46
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company is almost debt free.
- Debtor days have improved from 65.6 to 42.9 days.
- Promoter holding has increased by 0.77% over last quarter.
Weaknesses
2- Stock is trading at 10.9 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 10 | 4 | 5 |
| Oscillators | Bullish | 2 | 4 | 3 |
| Moving Averages | Strong Bearish | 8 | 0 | 2 |
Oscillators
Bullish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 38.55
- Neutral
- MACD (12,26,9)
- −17.40
- Bearish
- SMA (50)
- 390.36
- Bearish
- SMA (200)
- 265.91
- Bullish
As of
Growth Rate
From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 3Y | +23.06% |
|---|---|
| 1Y | +24.24% |
Net profit
| 3Y | +35.72% |
|---|---|
| 1Y | +66.67% |
Operating cash flow
| 3Y | +58.74% |
|---|---|
| 1Y | +300.00% |
Operating margin· change in pp
| 3Y | −0.44 pp |
|---|---|
| 1Y | +2.59 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2022 | ₹23.00 Cr |
|---|---|
| Mar 2023 | ₹22.00 Cr |
| Mar 2024 | ₹24.00 Cr |
| Mar 2025 | ₹33.00 Cr |
| Mar 2026 | ₹41.00 Cr |
Net profit by year
| Mar 2022 | ₹3.00 Cr |
|---|---|
| Mar 2023 | ₹4.00 Cr |
| Mar 2024 | ₹5.00 Cr |
| Mar 2025 | ₹6.00 Cr |
| Mar 2026 | ₹10.00 Cr |
Half-yearly Results
₹ Cr| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 13 | 19 | 21 | 20 |
| Expenses | 10 | 15 | 15 | 14 |
| Operating Profit | 4 | 4 | 6 | 6 |
| OPM % | 27% | 22% | 27% | 29% |
| Other Income | 0 | 0 | 2 | 1 |
| Interest | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 |
| PBT | 4 | 5 | 7 | 6 |
| Tax % | 26% | 27% | 24% | 28% |
| Net Profit | 3 | 3 | 6 | 4 |
| EPS (₹) | 2.65 | 3.15 | 3.87 | 3.13 |
Profit & Loss
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 23 | 22 | 24 | 33 | 41 |
| Expenses | 19 | 16 | 18 | 25 | 29 |
| Operating Profit | 4 | 6 | 6 | 8 | 11 |
| OPM % | 19% | 26% | 26% | 24% | 28% |
| Other Income | 1 | 1 | 1 | 1 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 1 | 1 | 1 | 1 |
| PBT | 4 | 5 | 7 | 8 | 13 |
| Tax % | 26% | 26% | 25% | 26% | 25% |
| Net Profit | 3 | 4 | 5 | 6 | 10 |
| EPS (₹) | 3.12 | 3.89 | 5.1 | 5.8 | 7.13 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 0.5 | 0.5 | 0.5 | 10 | 14 |
| Reserves | 13 | 17 | 22 | 18 | 40 |
| Borrowings | 2 | 0 | 0 | 0 | 0 |
| Other Liabilities | 7 | 6 | 5 | 5 | 12 |
| Total Liabilities | 22 | 24 | 28 | 34 | 67 |
| Fixed Assets | 8 | 7 | 7 | 7 | 16 |
| CWIP | 0 | 0 | 0 | 0 | 2 |
| Investments | 1 | 1 | 2 | 2 | 2 |
| Other Assets | 14 | 15 | 19 | 25 | 47 |
| Total Assets | 22 | 24 | 28 | 34 | 67 |
Cash Flow
₹ Cr| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 2 | 2 | 2 | 2 | 8 |
| Investing | −1 | 0 | −1 | −1 | −21 |
| Financing | −1 | −2 | 0 | 0 | 15 |
| Net Cash Flow | 1 | 0 | 0 | 1 | 3 |
| Free Cash Flow | 1 | 1 | 2 | 2 | 6 |
| CFO/EBITDA | 88 | 53 | 52 | 53 | 101 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 41 | 85 | 80 | 73 | 43 |
| Inventory Days | 59 | 58 | 106 | 112 | 138 |
| Days Payable | 161 | 162 | 116 | 57 | 44 |
| Cash Conversion Cycle | −60 | −19 | 71 | 128 | 138 |
| Working Capital Days | −51 | 15 | 62 | 95 | 91 |
| ROCE % | — | 33% | 34% | 32% | 30% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Cryogenic OGS insights
49 extracted metrics across FY22–FY26.
Documents
- Concall · May 2026PPT
- Concall · Jan 2026Transcript
- Concall · Oct 2025PPT
- General announcements 17 Oct 2026
Frequently Asked Questions about Cryogenic OGS
What does Cryogenic OGS Ltd do?
Where is Cryogenic OGS Ltd (CRYOGENIC) listed?
Which sector does Cryogenic OGS Ltd belong to?
What is the 52-week high and low of Cryogenic OGS Ltd?
What is the Return on Equity (ROE) of Cryogenic OGS Ltd?
Company Information
Incorporated in 1997, Cryogenic OGS Ltd provides equipment solutions for Metering, Filtering, Pressure Reduction, Dosing, and Blending.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544440.md for Cryogenic OGS Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.